If Optiscan can run to $0.27 with no announcement, no apparent news, imagine what will happen when the current trials relieve people of the need for a second surgery, I can only imagine how devastating both giving and receiving that news must be - so any improvement to the outcome of breast cancer surgery will indeed be great news for doctors, surgeons, patients and investors, all over the world.
Looking for reasons?
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.002(2.47%) |
Mkt cap ! $69.33M | |||
| Open | High | Low | Value | Volume |
| 8.3¢ | 8.4¢ | 8.2¢ | $2.228K | 26.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4301 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 14219 | 1 |
View Market Depth
| Last trade - 15.46pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.6¢ |
Change
0.002 ( 4.88 %) |
||||
| Open | High | Low | Volume | ||
| 8.3¢ | 8.6¢ | 8.3¢ | 6950 | ||
| Last updated 13.48pm 03/05/2024 ? | |||||
| OIL (ASX) Chart |